Ocunexus Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for ocular diseases. The company specializes in advancing novel treatment modalities that target unmet medical needs in the field of ophthalmology. By leveraging cutting-edge research and technology, Ocunexus aims to improve patient outcomes and enhance the quality of life for individuals suffering from various eye conditions. Its commitment to scientific excellence drives the development of transformative solutions in eye care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#534 in San Diego, CA

#7,114 in California

#29,866 in US

#56,047 in the World

San Diego, CA, United States of America

Ocunexus Therapeutics, Inc.

Forward Citations = 0

9 inventors:

Colin Richard Green (10 out of 31 patents)

Wilda Laux (4 out of 6 patents)

Bradford James Duft (4 out of 19 patents)

4. Yeri Kim (2 out of 2 patents)

5. Anthony Phillips (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ocunexus Therapeutics, Inc.. Retrieved from https://idiyas.com/company/ocunexus-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]